Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;12 Suppl 2(Suppl 2):S186-92.
doi: 10.1513/AnnalsATS.201502-088AW.

Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation

Affiliations
Review

Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation

Bethany B Moore et al. Ann Am Thorac Soc. 2015 Nov.

Abstract

Viral infections are important contributors to exacerbation of asthma and chronic obstructive pulmonary disease; however, the role of viruses in the pathogenesis of idiopathic pulmonary fibrosis (IPF) is less clear. This likely reflects that fact that IPF acute exacerbations are defined clinically as "noninfectious," and little attention has been paid to the outcomes of patients with IPF with diagnosed infections. However, accumulating evidence suggests that infections (both bacterial and viral) may influence disease outcomes either as exacerbating agents or initiators of disease. Support for a viral role in disease initiation comes from studies demonstrating the presence of herpesviral DNA and epithelial cell stress in the lungs of asymptomatic relatives at risk for developing familial IPF. In addition, the number of studies that can associate viral (especially herpesviral) signatures in the lung with the development of IPF is steadily growing, and activated leukocyte signatures in patients with IPF provide further support for infectious processes driving IPF progression. Animal modeling has been used to better understand how a gamma herpesvirus infection can modulate the pathogenesis of lung fibrosis and has demonstrated that preceding infections appear to reprogram lung epithelial cells during latency to produce profibrotic factors, making the lung more susceptible to subsequent fibrotic insult, whereas exacerbations of existing fibrosis, or infections in susceptible hosts, involve active viral replication and are influenced by antiviral therapy. In addition, there is new evidence that bacterial burden in the lungs of patients with IPF may predict a poor prognosis.

Keywords: aging; fibroblast; herpesvirus; immunity; lung.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Potential mechanisms for viral influence on the etiology or exacerbation of idiopathic pulmonary fibrosis (IPF) based on pathogenic mechanisms uncovered in animal models. (Top) Preceding infection may help initiate IPF pathogenesis by reprogramming of lung cells during latent infection. (Middle) Exacerbation of existing fibrosis likely involves lytic replication. (Bottom) Aged lungs or genetically susceptible hosts may be able to clear the lytic infection, but, due to alterations in the lung environment (e.g., increased sensitivity to transforming growth factor β [TGF-β]), the outcome of infection leads to fibrosis. ER = endoplasmic reticulum.

References

    1. Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, Gross BH, Myers J, Travis WD, Colby TV, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;181:832–837. - PMC - PubMed
    1. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174:810–816. - PubMed
    1. Collard HR. The age of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;181:771–772. - PubMed
    1. Xaubet A, Ancochea J, Bollo E, Fernández-Fabrellas E, Franquet T, Molina-Molina M, Montero MA, Serrano-Mollar A Sociedad Española de Neumología y Cirugía Torácica (SEPAR) Research Group on Diffuse Pulmonary Diseases. Guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis. Arch Bronconeumol. 2013;49:343–353. - PubMed
    1. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE, Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636–643. - PMC - PubMed

Publication types